Valuation: Brooks Laboratories Limited

Market Cap 1.75B 18.24M 16.02M 15.09M 13.8M 25.79M 26.01M 181M 70.19M 891M 68.47M 66.98M 2.9B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.77B 18.43M 16.19M 15.25M 13.95M 26.06M 26.29M 183M 70.93M 901M 69.19M 67.68M 2.93B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
09-16 Brooks Laboratories Limited Announces Resignation of Krutika Rane as Company Secretary and Compliance Officer (Key Managerial Personnel), Effective October 9, 2026 CI
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-18 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-06 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
28/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day-2.62%
1 week-2.65%
Current month-10.73%
1 month-1.00%
3 months-19.19%
6 months+29.05%
Current year-25.88%
1 week 58.67
Extreme 58.67
63.89
1 month 58.22
Extreme 58.22
71.4
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
146.95
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 22/01/2002
Chief Executive Officer - 31/05/2026
President 57 22/08/2023
Director TitleAgeSince
Director/Board Member 53 22/11/2022
Director/Board Member 62 09/09/2010
Director/Board Member - 22/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%-2.65%-59.29%-37.80% 18.76M
-0.81%-0.19%+13.41%+63.37% 46.71B
-0.72%+1.24%+37.33%+106.94% 36.9B
+0.87%+6.57%+12.96%+98.17% 12.18B
+1.16%+3.02%-8.39%+17.97% 11.66B
0.00%-0.95%+20.37%+140.74% 8.97B
-1.80%+0.85%+20.51%+202.74% 7.29B
-0.16%+0.40%+26.12%+37.50% 7.21B
+0.77%+3.33%+40.01%-16.11% 7.09B
-2.45%+1.48%-44.81%+8.04% 5.12B
Average -0.58%+1.18%+5.82%+62.16% 14.32B
Weighted average by Cap. -0.43%+0.64%+18.43%+78.58%

Financials

2025 2026
Net sales 826M 8.6M 7.56M 7.12M 6.51M 12.17M 12.27M 85.3M 33.12M 421M 32.31M 31.6M 1.37B 857M 8.94M 7.85M 7.39M 6.76M 12.64M 12.75M 88.59M 34.39M 437M 33.55M 32.82M 1.42B
Net income -99.67M -1.04M -913K -859K -786K -1.47M -1.48M -10.3M -4M -50.77M -3.9M -3.82M -165M 246M 2.56M 2.25M 2.12M 1.94M 3.62M 3.65M 25.4M 9.86M 125M 9.62M 9.41M 407M
Net Debt 75.39M 786K 690K 650K 595K 1.11M 1.12M 7.79M 3.02M 38.41M 2.95M 2.89M 125M 18.44M 192K 169K 159K 145K 272K 274K 1.91M 740K 9.39M 722K 706K 30.53M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
24/09/26 ₹59.40 -2.62% 26,893
23/09/26 ₹61.00 +3.23% 78,607
22/09/26 ₹59.09 0.00% 24,690
21/09/26 ₹59.09 -3.97% 86,961
18/09/26 ₹61.53 +0.49% 38,012
  1. Stock Market
  2. Stocks
  3. BROOKS Stock